Pranil K. Chandra, DO to Present at 9th Annual Personalized & Precision Medicine Conference

Brentwood, TN – (Thursday, October 12, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra will present at the 9th Annual Personalized and Precision Medicine Conference held October 16 – 17, 2017 in Orlando, Florida. Dr. Chandra currently serves as Vice President and Chief Medical Officer of Genomic and Clinical Pathology.

To see the full release, please CLICK HERE

Sandeep Mukherjee, Ph.D., to Present at Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting

Brentwood, TN – (Thursday, August 10, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Sandeep Mukherjee will present a poster abstract entitled “Prevalence of Mycoplasma genitalium in a Screening Population” at the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG) Annual Meeting held August 10-12, 2017 in Park City, Utah.

To see the full release, please click HERE

Lennon, Chandra and Olds to Present at Cancer Genomics Consortium 2017 Summer Meeting

Brentwood, TN – (Monday, August 7, 2017) – PathGroup is pleased to announce that Alan Lennon, Ph.D., FACMG, is serving as the current President-Elect for the Cancer Genomics Consortium. He is also serving as the 2017 Scientific Committee Chair for the 2017 Summer Meeting held August 7- 9, 2017 in Denver, Colorado.  Dr. Lennon currently serves as the Senior Scientific Director, Clinical Cytogenetics, FISH and Microarray Services for PathGroup.

To see the full release, please click HERE

Pranil K. Chandra, DO to Serve on Association for Molecular Pathology (AMP) Solid Tumors Practice Committee

Brentwood, TN – (Thursday, August 3, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra has been selected to serve a two-year term on the Solid Tumors Clinical Practice Committee for the Association for Molecular Pathology (AMP).

To read the full release, please click HERE

PathGroup’s Pranil K. Chandra, DO, FCAP, FASCP to Speak at 2017 Molecular Medicine Tri-Conference

Brentwood, TN – (Thursday, February 16, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that Pranil K. Chandra, DO, FCAP, FASCP,  Vice President and Chief Medical Officer and Medical Director,  Genomic and Clinical Pathology Services at PathGroup, will speak at the 2017 Molecular Medicine Tri-Conference  in San Francisco, CA on Monday, February 20, 2017.

Dr. Chandra’s session “Garnering Payer Support for Genomic Profiling by Demonstrating Clinical Utility” will review PathGroup’s experience with certain payers in garnering appropriate reimbursement for genomic profiling. In addition, he will review how to demonstrate clinical utility through illustrative examples highlighting diagnostic, prognostic, and/or therapeutic utility across hematologic and solid tumor malignancies.

For more information on the 2017 Molecular Medicine Tri-Conference please visit, http://www.triconference.com

PathGroup, CDC and the California Department of Public Health Partner to Improve Cancer Care with Big Data

– Enhanced cancer data and reporting standards for state cancer registries enable structured, real-time, data-driven decision making for cancer treatment specialists and patients

BRENTWOOD, Tenn., (Nov. 29, 2016)PathGroup, one of the largest private providers of anatomic pathology and clinical lab services in the U.S., today announced a new partnership with the Centers for Disease Control and Prevention (CDC) and the California Department of Public Health that standardizes nationwide state cancer registry data and reporting, enabling physicians, surgeons and researchers to make data-driven treatment decisions with real-time information and analyses.

For Full Release, CLICK HERE

CDC Recognizes PathGroup as First National Laboratory to Structure Cancer Pathology and Biomarker Data

Brentwood, TENN (November 11, 2016) – PathGroup, one of the largest private providers of pathology services in the Unites States, is pleased to be recognized by The Centers for Disease Control and Prevention (CDC) as the first national laboratory in the United States to standardize and structure cancer pathology and biomarker data reporting from its laboratory information system (LIS) to all state cancer registries.

PathGroup implemented standardized reporting in its proprietary system using the electronic Cancer Checklists (eCC) published by the College of American Pathologists (CAP). State cancer registries across the country will now electronically receive accurate and near real time cancer data.

Click Here to read the entire release from the CDC.

PathGroup Pathologist Co-Authors Molecular Pathology Publication

Dr. Pranil K. Chandra, Assistant Vice President and Medical Director of Molecular Pathology and Genomic Medicine Services at PathGroup, has co-authored a publication titled “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology”.

The Association of Molecular Pathology (AMP) report addresses the challenges in defining the clinical utility of molecular diagnostics for inherited disease and cancer, including molecular diagnostic procedures used for diagnosis, prognosis, risk assessment, prediction of future disease, and monitoring and selection of therapies of disease in patients.  The report puts forth clinical utility definitions that appropriately recognize the contribution and value of molecular diagnostic testing to improve patient care.

The report has been released online ahead of publication in the September 2016 issue of The Journal of Molecular Diagnostics.  Click Here to read the full manuscript.